Pharmacological Analysis of Modified Simiao Powder on Gouty Arthritis and Hyperuricemia

ZENG Wan-ping; YIN Lian; SHI Le; PAN Hong-ying; SONG Heng-wen; LIANG Yu-qiong; XU Li

doi:10.13422/j.cnki.syfjx.201413000

您当前的位置：

首页 >

文章列表页 >

Pharmacological Analysis of Modified Simiao Powder on Gouty Arthritis and Hyperuricemia

更新时间：2024-01-04

- Pharmacological Analysis of Modified Simiao Powder on Gouty Arthritis and Hyperuricemia
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 13, Pages: 129-133(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.201413000
  CLC： R285.5
- Published：2014
- 稿件说明：
移动端阅览
ZENG Wan-ping, YIN Lian, SHI Le, et al. Pharmacological Analysis of Modified Simiao Powder on Gouty Arthritis and Hyperuricemia[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(13): 129-133.
DOI：

ZENG Wan-ping, YIN Lian, SHI Le, et al. Pharmacological Analysis of Modified Simiao Powder on Gouty Arthritis and Hyperuricemia[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(13): 129-133. DOI： 10.13422/j.cnki.syfjx.201413000.

摘要

目的：考察加味四妙方抗高尿酸血症及痛风性关节炎的作用。方法： SD大鼠60只随机分为空白组、模型组、别嘌醇组（60 mg·kg-1）、加味四妙方高、中、低剂量组（24，12，6 g·kg-1）6组（n=10）。除空白组外，其他组喂食次黄嘌呤饲料，喂饲后第1，3，5天sc氧嗪酸钾复制高尿酸血症模型，于喂饲后第1天ig给药，连续5 d。检测血尿酸（UA），尿UA水平及血液、肝脏黄嘌呤氧化酶（XO）活性。新西兰兔40只随机分为模型组、秋水仙碱组（0.3 mg·kg-1）、加味四妙方高、中、低剂量组（12，6，3 g·kg-1）5组（n=8）。连续ig给药5 d后，各组家兔膝关节腔注射尿酸钠结晶（MSU）诱导痛风性关节炎模型。检测关节肿胀度，关节液白细胞计数（WBC），白细胞介素-1β（IL-1β），白细胞介素-6（IL-6）水平及关节囊、滑膜组织病变程度。结果：高尿酸血症模型大鼠与空白组比较，血UA，尿UA及血液XO，肝脏XO均明显上升（P<0.01）；加味四妙方高、中、低剂量组能降低高尿酸血症模型大鼠血UA，尿UA（P<0.01，P<0.05），且能显著降低血液XO（P<0.01）。对由MSU引起的家兔膝关节肿胀，在致炎后1，3，5 h，痛风模型家兔与空白组比较，关节液WBC及IL-1β，IL-6含量均明显上升（P<0.01）；加味四妙方高、中剂量组能抑制其肿胀度（P<0.01，P<0.05），显著降低关节液WBC及IL-1β，IL-6含量（P<0.01，P<0.05），且高剂量组能减轻关节组织病变程度（P<0.05）。结论：加味四妙方对高尿酸血症模型大鼠有降UA作用，并对痛风模型家兔有良好的抗炎作用，其作用机制可能与降低XO活性，抑制关节IL-1β，IL-6合成与释放有关。

Abstract

Objective: To explore the effects of Modified Simiao powder on gouty arthritis and hyperuricemia. Method: Sixty SD rats were randomly divided into 6 groups:the control group

model group

6 g·kg-1 Modified Simiao powder groups and allopurinol group

10 rats in each group. The rat hyperuricemia model was established by hypoxanthine and oteracil potassium

the level of serum and urinary uric acid

the activity of serum and liver xanthine oxidase were detected. Forty rabbits were randomly divided into 5 groups:the model group

3 g·kg-1 Modified Simiao powder groups and colchicine group (n=8). Rabbit acute gouty arthritis model was established by monosodium urate(MSU) intraarticular injection

the joint swell and articular lesions degree

white blood cell count

interleukin(IL) -1β and IL-6 in synovia were also measured. Result: Modified Simiao powder 24

6 g·kg-1 ig could significantly reduce the serum and urinary uric acid level in hyperuricemic rat (P<0.01

P<0.05)

together with decreasing liver xanthine oxidase activity (P<0.01). Modified Simiao powder 12

6 g·kg-1 ig could obviously restrain the joint swelling degree in the gouty arthritis modeling rabbits 1

5 h after modeling (P<0.01

P<0.05). White blood cell(WBC)

IL-1β and IL-6 levels were also decreased significantly after administration (P<0.01

P<0.05)

meanwhile

12 g·kg-1 ig could significantly reduce the articular lesions degree (P<0.05). Conclusion: Modified Simiao powder could obviously decrease urea acid(UA) of hyperuricacidemia modeling rats

and anti-inflammatory of gouty arthritis modeling rabbist. The mechanisms of its effects may liet in decreasing xanthine oxidase(XO) activity and restraining the synthesis of IL-1β

IL-6 in joint.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of Hyperuricemia and Gouty Arthritis by Buyang Huanwu Tongfeng Decoction via Inhibition of PPAR-γ/NF-κB/AGEs/RAGE Pathway Based on Network Pharmacology

Exploring Efficacy and Mechanism of Saffron Floral Bio-residues for Treatment of Hyperuricemia Combined with Gouty Arthritis Based on Compound Compatibility Environment

Effect of Alcohol Extract of Oroxylum indicum on Reducing Uric Acid and Protecting Kidney in Hyperuricemia Mice

Related Author

CAO Yue

YAO Wanmei

YANG Tao

YANG Man

JIA Ruimin

LU Rongrong

FENG Xue

LIU Biwang

Related Institution

Shanxi University of Chinese Medicine

Prescription and Drug Compatibility and Function Research Laboratory Supported by Shanxi Provincial Administration of TCM，Shanxi University of Chinese Medicine

Experimental Research Center，China Academy of Chinese Medical Sciences

Shandong University of Traditional Chinese Medicine（TCM）

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰